Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Generation Bio Co. (GBIO : NSDQ)

• Company Description    Generation Bio Co. is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases. The company is developing distinct and complementary platforms a potent, highly selective cell-targeted lipid nanoparticle delivery system and a novel immune-quiet DNA cargo produced by a scalable capsid-free manufacturing process which uses proprietary cell-free rapid enzymatic synthesis. Generation Bio Co. is based in CAMBRIDGE, Mass. Number of Employees: 115

• Price / Volume Information    Yesterday's Closing Price: $5.68 Daily Weekly Monthly 20 Day Moving Average: 61,104 shares Shares Outstanding: 6.74 (millions) Market Capitalization: $38.27 (millions) Beta: 2.05 52 Week High: $12.40 52 Week Low: $3.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.81% 9.00% 12 Week -9.98% -11.44% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 BINNEY STREET - CAMBRIDGE,MA 02142 USA ph: 617-655-7500 fax: - investors@generationbio.com http://www.generationbio.com

• General Corporate Information    Officers Geoff McDonough - Chief Executive Officer and President Kevin Conway - Chief Financial Officer Dannielle Appelhans - Director Ron H.W. Cooper - Director Jeffrey Jonas - Director Peer Information Generation Bio Co. (CORR.) Generation Bio Co. (RSPI) Generation Bio Co. (CGXP) Generation Bio Co. (BGEN) Generation Bio Co. (GTBP) Generation Bio Co. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 37148K209 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/12/26 Share - Related Items Shares Outstanding: 6.74 Most Recent Split Date: 7.00 (0.10:1) Beta: 2.05 Market Capitalization: $38.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.76 Price/Cash Flow: - Price / Sales: 2.51 EPS Growth vs. Year Ago Period: 64.35% vs. Previous Quarter: 73.72% Sales Growth vs. Year Ago Period: -78.90% vs. Previous Quarter: 108.37% ROE 12/31/25 - - 09/30/25 - -94.82 06/30/25 - -91.07 ROA 12/31/25 - - 09/30/25 - -34.13 06/30/25 - -33.65 Current Ratio 12/31/25 - - 09/30/25 - 4.44 06/30/25 - 7.51 Quick Ratio 12/31/25 - - 09/30/25 - 4.44 06/30/25 - 7.51 Operating Margin 12/31/25 - - 09/30/25 - -410.13 06/30/25 - -341.12 Net Margin 12/31/25 - - 09/30/25 - -410.13 06/30/25 - -341.12 Pre-Tax Margin 12/31/25 - - 09/30/25 - -410.13 06/30/25 - -341.12 Book Value 12/31/25 - - 09/30/25 - 7.51 06/30/25 - 8.03 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©